Suggestions
Pierre Socha
Partner @ Amadeus Capital
Pierre Socha is a Partner at Amadeus Capital Partners in Cambridge, England, with a focus on Health and Bio sectors.13 He joined Amadeus in 2012 and has since led investments in several innovative companies, including Constructive Bio, where he serves as a Board Member.14
Socha has a strong background in venture capital, business strategy, and biotechnology. Prior to joining Amadeus, he worked as an analyst at Natexis in France and later became an entrepreneur with PE-backed biotech Avesthagen in India, where he held positions such as CEO of the Bionutrition division and Chief Strategy Officer.36
His educational background includes:
- MSc in Maths and Econometrics from Aix-Marseille University, France
- Executive programs at Stanford, MIT, and Harvard Business School36
At Amadeus Capital Partners, Socha has led investments in companies such as:
- ConstructiveBio (synthetic biology)
- OriBiotech (cell and gene therapy manufacturing)
- PhoreMost (protein degradation)
- Quibim (imaging biomarker specialist)
- Natrox (advanced wound therapy)
- V7 (computer vision platform)
- Charco (Parkinson's therapy developer)
- Doctify (care review platform)3
Socha is known for his expertise in regenerative medicine and has expressed excitement about its potential to treat biological root causes of diseases and disorders.2 He is actively involved in the biotech and healthcare investment landscape, supporting innovative companies that are developing cutting-edge technologies and solutions.45
Highlights
💥 Today Philips announced its global partnership with imaging biomarker specialist Quibim on AI-based imaging and reporting solutions for MR prostate exams.
From tomorrow all MRIs sold by Philips will incorporate Quibim leading #oncology algorithms. 🚀
And #prostatecancer is just the beginning - “The collaboration with Quibim will ultimately be extended to address other forms of cancer beyond prostate, where there is a need to improve efficiency and mitigate staff shortages while delivering high-quality oncology care to an increasing number of patients.” - Philips
Unbelievable to see how much Ángel Alberich-Bayarri and team Quibim have achieved since our first investment.
Can’t wait to announce what’s coming next for them!!
Amadeus Capital Partners Partech Adara Ventures APEX Ventures K FUND LifeX Ventures Meltwind Advisory LLP #artificialintelligence #radiology #computervision #deeptech #cancer European Society for Radiotherapy and Oncology (ESTRO) European Society of Radiology #biomarkers
https://lnkd.in/evgPZke9
